Ex parte BHARGAVA et al. - Page 7




          Appeal No. 1997-4321                                                        
          Application No. 08/050,693                                                  


          would have been considered truly unexpected by one of ordinary              
          skill in the art in light of the Wang disclosure.  In re Merck              
          & Co., 800 F.2d 1091, 1099,                                                 
          231 USPQ 375, 381 (Fed. Cir. 1986); In re Klosak, 455 F.2d                  
          1077, 1080, 173 USPQ 14, 16 (CCPA 1972).  Furthermore, the                  
          examiner has lodged the valid criticism that the specification              
          results are hardly commensurate in scope with the degree of                 
          protection sought by appealed claim 11, which embraces any                  
          semiconductor material of the recited diameter having a dopant              
          level of less than 1%.  In re Grasselli, 713 F.2d 731, 743,                 
          218 USPQ 769, 778 (Fed. Cir. 1983); In re Clemens, 622 F.2d                 
          1029, 1035, 206 USPQ 289, 296 (CCPA 1980).                                  
               In conclusion, based on the foregoing, the examiner's                  
          decision rejecting the appealed claims is affirmed.                         












                                         -7-                                          





Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007